Draškovič Tina, Omahen Lara, Jerše Maja, Zidar Nina, Hauptman Nina
Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.
Cancers (Basel). 2024 Nov 29;16(23):4000. doi: 10.3390/cancers16234000.
: Gastric and lung adenocarcinomas are among the most common adenocarcinomas worldwide. Our research aimed to validate methylation biomarkers that differentiate gastric and lung adenocarcinomas from hepatocellular carcinoma, cholangiocarcinoma, colorectal carcinoma, pancreatic adenocarcinoma and paired healthy tissues. : The study analyzed 178 formalin-fixed, paraffin-embedded tissue samples, including 14 gastric adenocarcinomas, 15 lung adenocarcinomas, 15 hepatocellular carcinomas, 15 cholangiocarcinomas, 15 colorectal carcinomas, 15 pancreatic adenocarcinomas and their paired healthy tissues. Methylation status was determined experimentally by methylation-sensitive high resolution melting. The diagnostic panels were validated on bioinformatics datasets from The Cancer Genome Atlas and Gene Expression Omnibus, comprising 1981 and 773 samples, respectively. Sensitivity, specificity, diagnostic accuracy and predictive values for each cancer type were calculated for the experimental, Gene Expression Omnibus and The Cancer Genome Atlas datasets. : The gastric cancer-specific panel showed a sensitivity of 78.6-83.9%, a specificity of 86.6-94.6% and a diagnostic accuracy of 89.9-96.1% to differentiate between all tumors, and a sensitivity of 78.6-83.9%, a specificity of 89.2-96.4% and a diagnostic accuracy of 88-96.1% to differentiate between all tumors and healthy tissues. The lung adenocarcinoma-specific panel showed a sensitivity of 61.1-93.3%, a specificity of 70.3-90.8% and a diagnostic accuracy of 74.2-90.6% to differentiate between all tumors, and a sensitivity of 61.1-93.3%, a specificity of 77.9-93.4% and a diagnostic accuracy of 79.2% to 93.1% to differentiate between all tumors and healthy tissues. : This study demonstrates the potential of using diagnostic methylation panels to differentiate gastric and lung adenocarcinomas from other common adenocarcinomas and paired healthy tissues.
胃癌和肺腺癌是全球最常见的腺癌类型。我们的研究旨在验证能够区分胃癌和肺腺癌与肝细胞癌、胆管癌、结直肠癌、胰腺腺癌以及配对健康组织的甲基化生物标志物。
该研究分析了178份福尔马林固定、石蜡包埋的组织样本,包括14例胃癌、15例肺癌、15例肝细胞癌、15例胆管癌、15例结直肠癌、15例胰腺腺癌及其配对的健康组织。通过甲基化敏感的高分辨率熔解实验确定甲基化状态。诊断面板在来自癌症基因组图谱(The Cancer Genome Atlas)和基因表达综合数据库(Gene Expression Omnibus)的生物信息学数据集上进行了验证,分别包含1981个和773个样本。针对实验数据集、基因表达综合数据库数据集和癌症基因组图谱数据集,计算了每种癌症类型的敏感性、特异性、诊断准确性和预测值。
胃癌特异性面板在区分所有肿瘤时,敏感性为78.6 - 83.9%,特异性为86.6 - 94.6%,诊断准确性为89.9 - 96.1%;在区分所有肿瘤和健康组织时,敏感性为78.6 - 83.9%,特异性为89.2 - 96.4%,诊断准确性为88 - 96.1%。肺腺癌特异性面板在区分所有肿瘤时,敏感性为61.1 - 93.3%,特异性为70.3 - 90.8%,诊断准确性为74.2 - 90.6%;在区分所有肿瘤和健康组织时,敏感性为61.1 - 93.3%,特异性为77.9 - 93.4%,诊断准确性为79.2% - 93.1%。
本研究证明了使用诊断性甲基化面板区分胃癌和肺腺癌与其他常见腺癌及配对健康组织的潜力。